Subscribe to Search results

The House of Lords heard how documents that had been disclosed by the Department of Health held by the claimants' solicitors, Blackett Hart & Pratt Solicitors, in the HIV litigation were returned. However, some 600 files were destroyed.

Published on:

Anita James showed her notebook which demonstrated the numbers of the missing files.

Published on:

Around early 2006 documents held by the claimants' solicitors in the HIV litigation were returned. However, these were copies of the documents rather than the Department of Health's original versions.

Published on:

The Scottish Executive released a large number of documents, some of which the Department of Health, in an internal memo, believed would "inevitably be copies of the ones destroyed by DH".

Published on:

William Connon instructed that a "definitive list" be compiled showing all sets of documents that were destroyed, when they were destroyed, the circumstances of destruction and "likelihood of the documents which had just been found by the solicitors being copies of some of the destroyed documents." Ministers also instructed that an independent legal expert review the documents returned from the claimants' solicitors in the HIV litigation.

Published on:

The Department of Health commissioned an independent legal expert to undertake an initial analysis of the documents that had been returned from the claimants' solicitors in the HIV litigation.

Published on:

The parents of a child with haemophilia complained about the lack of recombinant Factor 8, even though the use of the product had been deemed "appropriate on clinical grounds" by the treating clinician.

Published on:

HM Customs and Excise decided that recombinant Factor 8 could no longer be considered exempt from VAT because it was not a biological product.

Published on:

The tax tribunal gave a detailed judgment when upholding HMCE in deciding that the sale of recombinant was liable to VAT. It recorded findings of fact that recombinant was "now considered as the treatment of choice by most clinicians and by the Haemophilia Society."

Published on:

The tax tribunal noted that recombinant had the advantages over blood-derived factor concentrate of being available in an unlimited supply, being a renewable source, and having freedom from blood-borne viral contamination. By comparison, purified plasma derived Factor 8 "might contain low levels of viral contamination."

Published on:

A Haemophilia Society Board of Trustees' meeting recorded the unequal availability of recombinant Factor 8 across the UK.

Published on:

The chair of the Haemophilia Society wrote to Stephen Dorrell reiterating the uneven availability of recombinant Factor 8 across the UK.

Published on:

A panel established by the Board of the Newcastle upon Tyne Hospitals NHS Trust recommended to the Board that "it support the universal availability of recombinant Factor VIII. This recommendation should be conveyed to Health Authorities for funding".

Published on:

Graham Barker, director of services and development at the Haemophilia Society, wrote a letter to Alf Morris MP indicating that some health authorities were refusing to pay the additional costs associated with recombinant Factor 8.

Published on:

Graham Barker wrote to Liz Lynne MP drawing attention to the Government's reluctance to adopt the UKHCDO guidelines and highlighting the difference in approach in Scotland where all children with Haemophilia A had been transferred to recombinant plans, by 1997.

Published on:

Jan Wallace described her involvement in Haemophilia Wales' campaign in 1997 which aimed to "ensure all haemophiliacs in Wales received the safest treatment known as Recombinant".

Published on:

Dr Ludlum raised concerns about the inequality of haemophilia care across the UK, in particular that of the very uneven availability of recombinant factor VIII.

Published on:

Beverley Tumelty set out the role her late brother, Gareth Lewis, played in campaigning for recombinant treatment for haemophiliacs in Wales. He was Chairman of the South Wales Haemophilia Group during this period.

Published on:

An Information Pack produced by the South Wales Haemophilia Group referred to their success in campaigning for Recombinant treatment for all haemophiliacs in Wales.

Published on:

Dr Graham Winyard and Dr Metters sent a memo to Baroness Jay regarding New Variant CJD and Blood.

Published on: